C12Treatment with Methylnaltrexone in Patients with Opioid-Induced Constipation with or without Active Cancer

Subcutaneous (SC) methylnaltrexone (MNTX, Relistor ®) is approved for opioid-induced constipation (OIC) in adults with chronic noncancer pain and OIC in adults with advanced illness or with active cancer who require opioid dosage escalation for palliative care. This post hoc analysis evaluated data pooled from 3 randomized studies of patients with advanced illness and OIC.
Source: Pain Management Nursing - Category: Nursing Authors: Source Type: research